Concern in Germany as safety of swine flu vaccines questioned - by Derek Scally
Germany's swine flu vaccination program has been hit by public health concerns over the vaccines being used – one of which has been ordered by the Irish Government. Germany’s 16 federal states have spent a reported €600 million buying 50 million doses of the Pandemrix vaccine, produced by GlaxoSmithKline (GSK). This new vaccine, one of two to be offered by Irish doctors, is the subject of controversy in Germany because it contains a “booster” substance known as an “adjuvant”. This allows less virus material to be used per dose and, according to GSK, boosts the immune system’s response to the jab.
No comments:
Post a Comment